A Phase II Study of Chlorambucil in Combination With Subcutaneous Rituximab Followed by Maintenance Therapy With Subcutaneous Rituximab in Patients With Extranodal Marginal Zone B-cell Lymphoma of Mucosa Associated Lymphoid Tissue (MALT Lymphoma)
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Chlorambucil (Primary) ; Rituximab (Primary) ; Rituximab (Primary)
- Indications B-cell lymphoma
- Focus Therapeutic Use
- 07 Jun 2021 Biomarkers information updated
- 22 Nov 2013 Planned initiation date (Dec 2013) added as reported by ClinicalTrials.gov.
- 18 Mar 2013 New trial record